RecruitingPHASE1, PHASE2NCT06921317

GVB-2001 Gene Therapy Via Intracameral Injection for the Treatment of Primary Open Angle Glaucoma

Studying NON RARE IN EUROPE: Primary adult open-angle glaucoma

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
IVIEW Therapeutics Inc.
Principal Investigator
Peirong Lu, MD
The First Affiliated Hospital of Soochow University
Intervention
GVB-2001-high dose(drug)
Enrollment
6 enrolled
Eligibility
18-70 years · All sexes
Timeline
20252027

Study locations (1)

Collaborators

The First Affiliated Hospital of Soochow University

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06921317 on ClinicalTrials.gov

Other trials for NON RARE IN EUROPE: Primary adult open-angle glaucoma

Additional recruiting or active studies for the same condition.

See all trials for NON RARE IN EUROPE: Primary adult open-angle glaucoma

← Back to all trials